gallic acid has been researched along with Uterine Cervical Neoplasms in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 5 (45.45) | 24.3611 |
| 2020's | 3 (27.27) | 2.80 |
| Authors | Studies |
|---|---|
| Andrade, JL; Borges, F; da Cruz, TG; Gomes, CA; Marques, MP; Milhazes, N | 1 |
| Bano, A; Bhardwaj, R; Vashishtha, A; Vats, R; Yadav, P | 1 |
| Akram, Z; Li, Y; Li, Z; Sun, S; Xie, Z; You, S; Yu, L; Zhang, J; Zhao, N | 1 |
| Aliyazicioglu, R; Aliyazicioglu, Y; Ayazoglu Demir, E; Deger, O; Demir, S; Mentese, A; Ozgen, U; Sener, SO; Yaman, SO | 1 |
| Boonsiri, P; Daduang, J; Daduang, S; Limpaiboon, T; Palasap, A; Suwannalert, P | 1 |
| Batista, MN; Braga, AC; Carneiro, BM; Cilli, EM; Lorenzón, EN; Rahal, P; Sanches, PR | 1 |
| Le, AD; Tang, XD; Zhang, QZ; Zhou, KY; Zhou, X | 1 |
| Han, YH; Moon, HJ; Park, WH; You, BR | 1 |
| Park, WH; You, BR | 1 |
| Kalaivani, T; Mathew, L; Rajasekaran, C | 1 |
| Fan, YB; Li, HX; Liu, YZ; Wang, Z; Yi, ZC; Yin, Y; Zhuang, FY | 1 |
11 other study(ies) available for gallic acid and Uterine Cervical Neoplasms
| Article | Year |
|---|---|
Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study.
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Caffeic Acids; Cell Division; Cell Line, Tumor; Cell Survival; Drug Screening Assays, Antitumor; Female; Gallic Acid; Humans; Leukemia, Lymphoid; Magnetic Resonance Spectroscopy; Models, Molecular; Molecular Conformation; Phenols; Spectrometry, Mass, Electrospray Ionization; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship; Uterine Cervical Neoplasms | 2003 |
A Phytochemicals Approach Towards the Treatment of Cervical Cancer Using Polyphenols and Flavonoids.
Topics: Antineoplastic Agents, Phytogenic; Cell Line, Tumor; Cell Proliferation; Female; Flavanones; Flavonoids; Gallic Acid; Humans; Phytochemicals; Phytotherapy; Polyphenols; Quercetin; Uterine Cervical Neoplasms | 2022 |
Construction of SLC16A1/3 Targeted Gallic Acid-Iron-Embelin Nanoparticles for Regulating Glycolysis and Redox Pathways in Cervical Cancer.
Topics: Female; Gallic Acid; Glycolysis; HeLa Cells; Humans; Iron; Molecular Docking Simulation; Nanoparticles; Oxidation-Reduction; Uterine Cervical Neoplasms | 2023 |
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Chromatography, High Pressure Liquid; Colonic Neoplasms; Fabaceae; Female; Gallic Acid; HeLa Cells; Humans; Male; Membrane Potential, Mitochondrial; Phenols; Plant Extracts; Quercetin; Uterine Cervical Neoplasms | 2020 |
Gallic acid enhancement of gold nanoparticle anticancer activity in cervical cancer cells.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; Drug Delivery Systems; Female; Gallic Acid; Gold; HeLa Cells; Human papillomavirus 16; Humans; Metal Nanoparticles; Papillomavirus Infections; Uterine Cervical Neoplasms; Vero Cells | 2015 |
A conjugate of the lytic peptide Hecate and gallic acid: structure, activity against cervical cancer, and toxicity.
Topics: Amino Acid Sequence; Antineoplastic Agents; Cell Survival; Drug Screening Assays, Antitumor; Erythrocytes; Female; Gallic Acid; HeLa Cells; Hemolytic Agents; Humans; Melitten; Molecular Sequence Data; Uterine Cervical Neoplasms | 2015 |
[Effects of green tea extract on expression of human papillomavirus type 16 oncoproteins-induced hypoxia-inducible factor-1alpha and vascular endothelial growth factor in human cervical carcinoma cells].
Topics: Catechin; Cell Line, Tumor; Female; Gallic Acid; Human papillomavirus 16; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Plant Extracts; Tea; Uterine Cervical Neoplasms; Vascular Endothelial Growth Factor A | 2008 |
Gallic acid inhibits the growth of HeLa cervical cancer cells via apoptosis and/or necrosis.
Topics: Adenocarcinoma; Antineoplastic Agents; Apoptosis; Cell Survival; Drug Screening Assays, Antitumor; Endothelium, Vascular; Female; Gallic Acid; Glutathione; HeLa Cells; Humans; Membrane Potential, Mitochondrial; Necrosis; Superoxides; Umbilical Veins; Uterine Cervical Neoplasms | 2010 |
The effects of mitogen-activated protein kinase inhibitors or small interfering RNAs on gallic acid-induced HeLa cell death in relation to reactive oxygen species and glutathione.
Topics: Cell Death; Female; Gallic Acid; Glutathione; HeLa Cells; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Reactive Oxygen Species; RNA, Small Interfering; Uterine Cervical Neoplasms | 2011 |
Free radical scavenging, cytotoxic, and hemolytic activities of an active antioxidant compound ethyl gallate from leaves of Acacia nilotica (L.) Wild. Ex. Delile subsp. indica (Benth.) Brenan.
Topics: Acacia; Animals; Antineoplastic Agents, Phytogenic; Antioxidants; Cell Proliferation; Chlorocebus aethiops; Erythrocytes; Female; Food Additives; Free Radical Scavengers; Gallic Acid; HeLa Cells; Hemolytic Agents; Humans; India; Inhibitory Concentration 50; Iron Chelating Agents; Plant Leaves; Rats; Rats, Inbred Strains; Uterine Cervical Neoplasms; Vero Cells | 2011 |
Tellimagrandin I enhances gap junctional communication and attenuates the tumor phenotype of human cervical carcinoma HeLa cells in vitro.
Topics: Antineoplastic Agents; Connexin 43; Disease Progression; Dose-Response Relationship, Drug; Drugs, Chinese Herbal; Female; Fluoresceins; Gallic Acid; Gap Junctions; Gene Expression Regulation, Neoplastic; Glucosides; HeLa Cells; Humans; Hydrolyzable Tannins; In Vitro Techniques; Isoquinolines; Phenotype; Uterine Cervical Neoplasms | 2006 |